Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy.
about
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritisTherapeutic targets in the ASK1-dependent stress signaling pathwaysAdvances in the treatment of rheumatoid arthritis.Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis.A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis.Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammationKinase inhibitors: a new class of antirheumatic drugsNew and emerging therapies for the treatment of rheumatoid arthritis.Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Tec family kinases in inflammation and disease.Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis.Current immunotherapy in rheumatoid arthritis.Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis.Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives.Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.TLRs, future potential therapeutic targets for RA.Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) Inhibitors.Clinically relevant advances in rheumatoid arthritis therapy.Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytes.[Update on kinase inhibitors].
P2860
Q24598633-3C14252B-CF7C-4745-AA0D-7C86AEF914FFQ26999030-9BF51CDC-7CB8-413D-84FA-B4EDCED0F89DQ27691822-F46A12AB-3693-42A7-B2C9-D8E2C1034683Q34677487-7FD57B3C-C43F-4580-8C65-7F01E9033297Q34881784-07483855-C58B-4800-BFBF-1FA35CDB7AC9Q35230204-ED2AF31A-A954-4174-A338-80283E0F418AQ36277831-58991F1F-F95A-41F6-A603-5527DC3B872EQ37358229-293423D3-F06F-4CA4-824A-D77D22196661Q37776270-96F17DAA-5670-47BF-B680-3008C7B92139Q37937555-FEBBF600-A6B7-48A9-898A-71795D06AE2FQ37943809-A3622B9C-785D-4426-89CE-C23E95381B8DQ37997073-C5A7B375-34C3-4F47-947F-4BD8D47D9C4AQ38078271-A4CD8B6E-82B4-4C44-BEEB-00C9AA5144F8Q38133655-861542FF-86F2-40BE-B6D8-D23F106C9BA8Q38181610-297CD89D-052E-45D0-AF76-07701EC15985Q38251801-0FC4D480-F4DB-49D5-B5D3-257764F35F98Q38697262-05826090-640B-4DDD-ABB2-2DBA84A19670Q38781354-E8E66804-E502-4253-AE9E-A4054C18F425Q39508065-D451C725-F83C-40E5-A51D-2A176AECF4F9Q39736497-FCC0FF74-439B-44C8-90F4-A978013741D3Q41838652-B7186BAF-31B7-47AD-B090-14BAAE10A02DQ42429559-BD481AC5-619D-4DF2-9979-39C7427D5341Q52850373-6201BA33-0DD4-41E8-8EEE-AE9826696714
P2860
Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en-gb
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@nl
type
label
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en-gb
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@nl
prefLabel
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en-gb
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@nl
P2093
P356
P1476
Efficacy and safety of pamapim ...... g stable methotrexate therapy.
@en
P2093
A Bertasso
F Irazoque
J P Caulfield
P304
P356
10.1136/ARD.2008.104802
P407
P50
P577
2009-04-08T00:00:00Z
P6179
1034176029